Geron market cap GERN

Share price times shares outstanding: what the whole company sells for, since 2011.

Geron is worth $719.6M at the close on Oct 23, 2026, at $1.12 a share.

That is down 9% over the last year and up 46% over five years.

Its highest close in our data was $2.9B in Jun 2024.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$719.6M	$719.6M	$1.2B	−18%
2025	$874.5M	$682.7M	$2.2B	−57%
2024	$2B	$993.8M	$2.9B	+77%
2023	$1.1B	$931.6M	$1.8B	+24%
2022	$922.6M	$325.2M	$1B	+135%
2021	$392.8M	$388.7M	$639.6M	−20%
2020	$493.7M	$192.3M	$620.9M	+79%
2019	$275.7M	$203.1M	$356M	+45%
2018	$190.1M	$182.6M	$1.1B	−34%
2017	$286.6M	$286.6M	$485.5M	−13%
2016	$329.4M	$299.2M	$613.9M	−57%
2015	$765.8M	$474.8M	$800.6M	+50%
2014	$509.4M	$223.1M	$684.8M	−14%
2013	$589.4M	$129.6M	$714.5M	+227%
2012	$180.4M	$130.8M	$359.6M	−2%
2011	$184.1M	$174.9M	$328.6M	n/a

Companies in Drug Manufacturers - General nearest Geron's size, closest first, today.

Company	Market cap
GERNGeron	$719.6M
COLLCollegium Pharmaceutical	$747.5M
ABUSArbutus Biopharma	$831M
CRMDCorMedix	$611.9M
ZVRAZevra Therapeutics	$582.6M
IRWDIronwood Pharmaceuticals	$571.7M
PBYIPuma Biotechnology	$568.9M
AMPHAmphastar Pharmaceuticals	$1.1B
ARVNArvinas	$477.3M
OMEROmeros	$1.2B
PCRXPacira BioSciences	$1.5B
Peer median	$679.7M